Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

BACKGROUND Renal impairment is associated with increased mortality in heart failure (HF). Recently, reports suggest that worsening renal function (WRF) is another predictor of clinical outcome in HF. The present study was designed to establish the proportion of patients with HF that exhibits (WRF) and the associated risk for mortality and hospitalization by conducting a systematic review and meta-analysis. METHODS AND RESULTS A systematic search of MEDLINE revealed 8 studies on the relationship between WRF and mortality in 18,634 patients with HF. The mortality risk associated with WRF was estimated using random-effects meta-analysis. WRF was defined as an increase in serum creatinine > or = 0.2 mg/dL or a corresponding decrease in estimated glomerular filtration rate > or = 5 mL x min x 1.73 m2. Subgroup analysis included differentiation between in- and out-hospital patients, degree of WRF and time until end point occurrence. WRF developed in 4,734 (25%) patients and was associated with a higher risk for mortality (odds ratio [OR] = 1.62; 95% confidence interval [CI] 1.45-1.82, P < .001) and hospitalization (OR = 1.30, 95% CI 1.04-1.62, P = .022). The severity of WRF was also associated with greater mortality. Patients with impaired renal function at baseline were more prone to progressive renal function loss. CONCLUSIONS WRF predicts substantially higher rates of mortality and hospitalization in patients with HF.

[1]  H. Krumholz,et al.  Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure. , 2000, The American journal of cardiology.

[2]  M. Komajda,et al.  Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). , 2006, European heart journal.

[3]  G. Beck,et al.  Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. , 1997, Kidney international.

[4]  C. Mulrow,et al.  Current methods of the US Preventive Services Task Force: a review of the process. , 2001, American journal of preventive medicine.

[5]  G. Navis,et al.  Drawbacks and Prognostic Value of Formulas Estimating Renal Function in Patients With Chronic Heart Failure and Systolic Dysfunction , 2006, Circulation.

[6]  A. Charlesworth,et al.  Renal function, neurohormonal activation, and survival in patients with chronic heart failure. , 2000, Circulation.

[7]  S. Solomon,et al.  Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. , 2006, Journal of the American Society of Nephrology : JASN.

[8]  B. Eriksen,et al.  The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. , 2006, Kidney international.

[9]  A. Burger,et al.  Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure. , 2004, The American journal of cardiology.

[10]  L. Stevenson,et al.  Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. , 1999, American heart journal.

[11]  W. Rand,et al.  Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. , 2001, Journal of the American College of Cardiology.

[12]  W. Markiewicz,et al.  Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. , 2005, American heart journal.

[13]  A. Rigby,et al.  Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure , 2007, European journal of heart failure.

[14]  J. Wetzels,et al.  Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. , 2006, Journal of the American Society of Nephrology : JASN.

[15]  K. Lemley,et al.  Determinants of glomerular hypofiltration in aging humans. , 2003, Kidney international.

[16]  G. Karth,et al.  Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. , 2002, The American journal of medicine.

[17]  S. Fishbane,et al.  Risk for Acute Renal Failure in Patients Hospitalized for Decompensated Congestive Heart Failure , 2007, American Journal of Nephrology.

[18]  P. Doevendans,et al.  Renal function; , 2004 .

[19]  C. O'connor,et al.  The prognostic importance of different definitions of worsening renal function in congestive heart failure. , 2002, Journal of cardiac failure.

[20]  V. Roger,et al.  Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients. , 2006, Journal of cardiac failure.

[21]  M. Domanski,et al.  The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. , 2000, Journal of the American College of Cardiology.

[22]  J. Levine,et al.  Predictors of worsening renal function in adult patients with congestive heart failure receiving recombinant human B-type brain natriuretic peptide (nesiritide). , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  Harlan M Krumholz,et al.  Renal impairment and outcomes in heart failure: systematic review and meta-analysis. , 2006, Journal of the American College of Cardiology.

[24]  D. Grobbee,et al.  Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. , 2003, European heart journal.

[25]  Douglas G Altman,et al.  Systematic reviews of evaluations of prognostic variables , 2001, BMJ : British Medical Journal.

[26]  A. Rigby,et al.  Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. , 2006, European heart journal.

[27]  K. A. McKibbon,et al.  Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey , 2005, BMJ : British Medical Journal.

[28]  William T. Abraham,et al.  Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness , 2005 .

[29]  H. Krumholz,et al.  Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? , 2002, Journal of cardiac failure.

[30]  C. O'connor,et al.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. , 2004, Journal of the American College of Cardiology.

[31]  A. Levin,et al.  Kidney function and mortality among patients with left ventricular systolic dysfunction. , 2005, Journal of the American Society of Nephrology : JASN.

[32]  C. O'connor,et al.  Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. , 2004, American heart journal.

[33]  Hans L. Hillege,et al.  Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure , 2006, Circulation.